Yeji
CRLconf 0.92

axs-14 — CRL

$AXSM · Axsome Therapeutics, Inc. · Management of fibromyalgia
Event date
June 9, 2025
362 days ago
Sponsor runway
44 mo
$305.1M liquid

Evidence

“Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it has received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for AXS-14 (esreboxetine) for the management of fibromyalgia.”
Source: Press release · 2025-06-09View press release ↗

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

6 insiders · 0 buys · 18 sells
Sell10b5-1
2025-09-05
Saad Mark E
Director
9,127 @ $125.07$1.14M
Exercise10b5-1
2025-09-05
Saad Mark E
Director
9,127 @ $9.00$82K
Sell10b5-1
2025-09-02
JEFFS ROGER
Director
13,464 @ $123.68$1.67M
Sell10b5-1
2025-08-29
JEFFS ROGER
Director
20,000 @ $121.27$2.43M
Sell10b5-1
2025-08-28
JEFFS ROGER
Director
20,000 @ $121.60$2.43M
Sell10b5-1
2025-08-27
JEFFS ROGER
Director
20,000 @ $122.30$2.45M
Sell10b5-1
2025-08-26
JEFFS ROGER
Director
20,000 @ $120.03$2.40M
Sell10b5-1
2025-08-22
JEFFS ROGER
Director
16,694 @ $120.08$2.00M
Sell10b5-1
2025-06-23
Murdock Hunter R.
General Counsel
6,014 @ $100.12$602K
Exercise10b5-1
2025-06-23
Murdock Hunter R.
General Counsel
6,014 @ $29.91$180K
Sell10b5-1
2025-06-20
Murdock Hunter R.
General Counsel
7,500 @ $102.47$769K
Exercise10b5-1
2025-06-20
Murdock Hunter R.
General Counsel
7,500 @ $29.91$224K
Exercise10b5-1
2025-06-18
Murdock Hunter R.
General Counsel
7,500 @ $29.91$224K
Sell10b5-1
2025-06-18
Murdock Hunter R.
General Counsel
7,500 @ $100.90$757K
Sell10b5-1
2025-06-17
Murdock Hunter R.
General Counsel
7,500 @ $100.26$752K
Exercise10b5-1
2025-06-17
Murdock Hunter R.
General Counsel
7,500 @ $29.91$224K
Exercise10b5-1
2025-06-16
Murdock Hunter R.
General Counsel
7,500 @ $29.91$224K
Sell10b5-1
2025-06-16
Murdock Hunter R.
General Counsel
7,500 @ $102.42$768K
Exercise10b5-1
2025-06-09
Jacobson Mark L.
Chief Operating Officer
25,000 @ $8.02$201K
Sell10b5-1
2025-06-09
Jacobson Mark L.
Chief Operating Officer
25,000 @ $110.44$2.76M
Grant
2025-06-06
Saad Mark E
Director
1,429 @ ——
Grant
2025-06-06
JEFFS ROGER
Director
3,166 @ ——
Grant
2025-06-06
JEFFS ROGER
Director
1,429 @ ——
Grant
2025-06-06
Mahony Susan
Director
3,166 @ ——
Grant
2025-06-06
Mahony Susan
Director
1,429 @ ——
Grant
2025-06-06
Coleman Mark
Director
3,166 @ ——
Grant
2025-06-06
Coleman Mark
Director
1,429 @ ——
Grant
2025-06-06
Saad Mark E
Director
3,166 @ ——
Sell10b5-1
2025-05-28
Coleman Mark
Director
3,750 @ $103.43$388K
Sell10b5-1
2025-05-28
Jacobson Mark L.
Chief Operating Officer
20,000 @ $103.45$2.07M
Exercise10b5-1
2025-05-28
Jacobson Mark L.
Chief Operating Officer
20,000 @ $6.47$129K
Sell10b5-1
2025-05-27
Jacobson Mark L.
Chief Operating Officer
20,673 @ $104.66$2.16M
Sell10b5-1
2025-05-27
Coleman Mark
Director
3,750 @ $105.47$396K
Exercise10b5-1
2025-05-27
Jacobson Mark L.
Chief Operating Officer
20,673 @ $6.47$134K
Sell
2025-05-20
Coleman Mark
Director
3,000 @ $107.49$322K
← All catalysts for $AXSM